Related Experiment Video

Updated: Aug 17, 2026

Isolation and Cannulation of Cerebral Parenchymal Arterioles
09:49

Isolation and Cannulation of Cerebral Parenchymal Arterioles

Published on: May 23, 2016

Contribution of PAI-1 in cardiovascular pathology

M C Alessi1, I Juhan-Vague

  • 1UMR INSERM 626, Faculté de médecine de la Timone, Marseille.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 31, 2004
PubMed

Insights

Plasminogen activator inhibitor-1 (PAI-1) impacts thrombosis and atherosclerosis, independent of its fibrinolysis role. Targeting PAI-1 may offer new insights into metabolic syndrome and insulin resistance processes.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Metabolic Diseases

Background:

  • Plasminogen activator inhibitor-1 (PAI-1) is a serpin that inhibits plasminogen activation and fibrinolysis.
  • PAI-1 is implicated in thrombosis, vascular healing, and atherosclerosis, with conflicting findings in the latter two.
  • High plasma PAI-1 levels are linked to poor myocardial infarction prognosis and coronary heart disease risk.

Purpose of the Study:

  • To explore the multifaceted roles of PAI-1 beyond fibrinolysis.
  • To investigate the association between PAI-1, metabolic syndrome, and cardiovascular disease.
  • To highlight the potential of PAI-1 inhibitors in treating atherosclerotic and insulin resistance processes.

Main Methods:

  • Review of studies on genetically modified mice to assess PAI-1's role in various conditions.
  • Analysis of clinical data linking plasma PAI-1 levels to patient prognosis and metabolic syndrome.
  • Discussion of potential therapeutic strategies targeting PAI-1.

Main Results:

  • PAI-1 exhibits roles in cellular processes independent of plasminogen activation, influencing thrombosis and atherosclerosis.
  • Contradictory findings in vascular healing and atherosclerosis models suggest context-dependent effects.
  • PAI-1's predictive capacity for cardiovascular events is strongly associated with metabolic syndrome components.

Conclusions:

  • PAI-1 plays a significant role in atherothrombosis, particularly within the context of metabolic syndrome.
  • The inflammatory state in metabolic syndrome contributes to elevated PAI-1 levels.
  • Modulating PAI-1 expression presents a potential therapeutic avenue for atherosclerotic and insulin resistance disorders.

More Related Videos

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies09:08

Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies

Published on: May 24, 2021

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...